Advanced search

1272 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	03/05	GL
Novo Nordisk A/S : Go to the Q1 2024 company announcement	02/05	PU
Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in the first three months of 2024	02/05	GL
Novo Nordisk A/S - share repurchase programme	01/05	GL
Transcript : Associated Banc-Corp, Q1 2024 Earnings Call, Apr 25, 2024	26/04
Bulletin from the Annual General Meeting on April 25, 2024 in Electrolux Professional AB (publ)	25/04	AQ
Novo Nordisk A/S : Reduction of the share capital	24/04	PU
Novo Nordisk A/S – Reduction of the share capital	24/04	GL
Novo Nordisk A/S - share repurchase programme	22/04	GL
Crimson Tide annual revenue jumps 15%; promotes COO Meyers to CEO	17/04	AN
Crimson Tide plc Announces CEO Changes	17/04	CI
National Association of Corporate Directors Announces Management Appointments	16/04	CI
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	15/04	GL
Novo Nordisk A/S - share repurchase programme	15/04	GL
Novo Nordisk A/S - share repurchase programme	08/04	GL
Precision Drilling : WELCOME TO OUR 2024 MANAGEMENT INFORMATION CIRCULAR - Form 6-K	04/04	PU
Novo Nordisk A/S - share repurchase programme	02/04	GL
Centene : Political Activity Report July 1, 2023 – December 31, 2023	26/03	PU
Novo Nordisk A/S - share repurchase programme	25/03	GL
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease	25/03	GL
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities	21/03	GL
Resolutions from the Annual General Meeting of Novo Nordisk A/S	21/03	AQ
Resolutions from the Annual General Meeting of Novo Nordisk A/S	21/03	GL
Transcript : VerifyMe, Inc., Q4 2023 Earnings Call, Mar 21, 2024	21/03
Notice convening the Annual General Meeting of Electrolux Professional AB (publ)	19/03	AQ
Novo Nordisk A/S - share repurchase programme	18/03	GL
Fondul Proprietatea : February 2024 Factsheet	14/03	PU
Novo Nordisk A/S - share repurchase programme	11/03	GL
Wegovy® approved in the US for cardiovascular risk reduction in people with overweight or obesity and established cardiovascular disease	09/03	GL
Novo Nordisk : Highlights to be presented at Novo Nordisk's Capital Markets Day 2024	07/03	PU
Highlights to be presented at Novo Nordisk’s Capital Markets Day 2024	07/03	GL
Highlights to be presented at Novo Nordisk’s Capital Markets Day 2024	07/03	AQ
2024 EGM Invitation: English \| German	06/03	PU
Novo Nordisk A/S: Semaglutide 1.0 mg demonstrates 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease in the FLOW trial	05/03	GL
Atlas Sand Company, LLC completed the acquisition of Permian Basin proppant production assets and North American logistics operations from Hi-Crush Inc. for approximately $440 million .	05/03	CI
Novo Nordisk A/S - share repurchase programme	04/03	GL
Novo Nordisk A/S - share repurchase programme	04/03	AQ
Transcript : Bystronic AG, 2023 Earnings Call, Feb 29, 2024	29/02
Everi Holdings Inc. signed a definitive agreement to acquire Global Gaming and PlayDigital Businesses of International Game Technology PLC from International Game Technology PLC for approximately $1.2 billion.	29/02	CI
Transcript : SunOpta Inc., Q4 2023 Earnings Call, Feb 28, 2024	29/02
European Midday Briefing : Investors Brace for Economic Data This Week	27/02	DJ
Atlas Sand Company, LLC entered into a definitive agreement to acquire Permian Basin proppant production assets and North American logistics operations from Hi-Crush Inc. for approximately $450 million.	27/02	CI
Transcript : Lincoln Educational Services Corporation, Q4 2023 Earnings Call, Feb 26, 2024	26/02
Novo Nordisk A/S - share repurchase programme	26/02	GL
Meyer Burger calls EGM to approve CHF 200 to 250 million rights issue to finance the completion of its Colorado and Arizona manufacturing facilities	23/02	EQ
Notice for the Annual General Meeting of Novo Nordisk A/S	21/02	GL
Novo Nordisk A/S – Share repurchase programme	19/02	GL
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	14/02	GL
Novo Nordisk A/S - share repurchase programme	12/02	GL
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	12/02	GL

No results for this search

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer